Oxadiazoanthracene compounds for the treatment of diabetes

Number of patents in Portfolio can not be more than 2000

United States of America Patent

PATENT NO 8933222
SERIAL NO

14197771

Stats

ATTORNEY / AGENT: (SPONSORED)

Importance

Loading Importance Indicators... loading....

Abstract

See full text

The present invention provides methods of synthesizing oxadiazoanthracene derivatives of the formula (I) and pharmaceutically acceptable salts thereof,

Loading the Abstract Image... loading....

First Claim

See full text

Family

Loading Family data... loading....

Patent Owner(s)

Patent OwnerAddress
VTVX HOLDINGS I LLC4170 MENDENHALL OAKS PKWY HIGH POINT NC 27265

International Classification(s)

  • [Classification Symbol]
  • [Patents Count]

Inventor(s)

Inventor Name Address # of filed Patents Total Citations
Behme, Christopher Jamestown, US 15 106
Davis, Stephen Thomas Durham, US 17 247
Guzel, Mustafa Jamestown, US 40 1025
Mjalli, Adnan M M Oak Ridge, US 93 1556
Polisetti, Dharma Rao High Point, US 60 1134
Santhosh, Kalpathy Jamestown, US 10 34
Yokum, Thomas Scott Greensboro, US 18 275

Cited Art Landscape

Load Citation

Patent Citation Ranking

Forward Cite Landscape

Load Citation

Maintenance Fees

Fee Large entity fee small entity fee micro entity fee due date
11.5 Year Payment $7400.00 $3700.00 $1850.00 Jul 13, 2026
Fee Large entity fee small entity fee micro entity fee
Surcharge - 11.5 year - Late payment within 6 months $160.00 $80.00 $40.00
Surcharge after expiration - Late payment is unavoidable $700.00 $350.00 $175.00
Surcharge after expiration - Late payment is unintentional $1,640.00 $820.00 $410.00